Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 11, 2019 | Hadean Ventures leads 40 million SEK (€3.7 million) investment round into SAGA to advance ultrasensitive cancer liquid biopsies | LUND, Sweden and OSLO, Norway, June 11, 2019 — /B3C Newswire/ — SAGA Diagnostics AB, a precision oncology genomics testing company focused on ultrasensitive monitoring of cancer patients using blood samples and other liquid biopsies and tis... |
| Jul 24, 2013 | Michael Cindric – founder of Sentia and Doccy | Michael Cindric played soccer at the highest level as a junior and senior, going on to play for Sydney United in the NSL before it became defunct and is still playing Semi-Professional football for Sydney Olympic. Having worked as an IT con... |
| INDUSTRIFONDEN JOINS GLIONOVA SEK 42 MILLION ($5.7 MILLION) FINANCING CO-LED BY HEALTHCAP AND NOVO | STOCKHOLM, December 09, 2014 – Glionova Therapeutics, an oncology-focused biopharmaceutical company today announced that Industrifonden has joined a SEK 42 million (US$ 5.7 million) Series A financing co-led by Novo Seeds and the company’s ... | |
| INDUSTRIFONDEN JOINS GLIONOVA SEK 42 MILLION ($5.7 MILLION) FINANCING CO-LED BY HEALTHCAP AND NOVO TO TAKE NOVEL THERAPY FOR GLIOBLASTOMA INTO CLINIC | STOCKHOLM, December 09, 2014 – Glionova Therapeutics, an oncology-focused biopharmaceutical company today announced that Industrifonden has joined a SEK 42 million (US$ 5.7 million) Series A financing co-led by Novo Seeds and the company’s ... |
Reviews 0
FAQ about SEK
What has the press written about SEK?
Parsers VC has collected 5 articles mentioning SEK, among them “Hadean Ventures leads 40 million SEK (€3.7 million) investment round into SAGA to advance ultrasensitive cancer liquid biopsies” (Jun 11, 2019) and “Michael Cindric – founder of Sentia and Doccy” (Jul 24, 2013).
Is SEK still active?
SEK is probably closed: its latest activity on Parsers VC dates from Jun 13, 2022.